blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3501527

EP3501527 - COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAININGLACTOBACILLUS [Right-click to bookmark this link]
StatusThe patent has been granted
Status updated on  02.02.2024
Database last updated on 13.07.2024
FormerGrant of patent is intended
Status updated on  11.10.2023
FormerExamination is in progress
Status updated on  30.06.2023
FormerRequest for examination was made
Status updated on  27.05.2019
FormerThe international publication has been made
Status updated on  24.02.2018
Most recent event   Tooltip12.07.2024Lapse of the patent in a contracting statepublished on 14.08.2024 [2024/33]
Applicant(s)For all designated states
MD Healthcare Inc.
(Sangam-dong, Woori Technology Bldg.)
1303, 9, World Cup buk-ro 56-gil
Mapo-gu
Seoul 03923 / KR
[2019/26]
Inventor(s)01 / KIM, Yoon-Keun
1707-805, 93 Hopyeong-ro
Namyangju-si Gyeonggi-do 12146 / KR
02 / HAN, Pyung lim
119-901, 163 Deungchon-ro
Gangseo-gu
Seoul 07671 / KR
03 / CHOI, Ju-Li
502 Dongwoo Vila
38 Yonsei-ro 2ma-gil
Seodaemun-gu
Seoul 03777 / KR
 [2019/26]
Representative(s)Dehns
St. Bride's House
10 Salisbury Square
London EC4Y 8JD / GB
[2024/10]
Former [2019/26]Dehns
St. Brides House
10 Salisbury Square
London EC4Y 8JD / GB
Application number, filing date17841640.009.08.2017
[2019/26]
WO2017KR08652
Priority number, dateKR2016010368016.08.2016         Original published format: KR 20160103680
KR2017008502004.07.2017         Original published format: KR 20170085020
KR2017010045908.08.2017         Original published format: KR 20170100459
[2019/26]
Filing languageKO
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018034457
Date:22.02.2018
Language:KO
[2018/08]
Type: A1 Application with search report 
No.:EP3501527
Date:26.06.2019
Language:EN
[2019/26]
Type: B1 Patent specification 
No.:EP3501527
Date:06.03.2024
Language:EN
[2024/10]
Search report(s)International search report - published on:KR22.02.2018
(Supplementary) European search report - dispatched on:EP02.04.2020
ClassificationIPC:A61K35/747, A23L33/135, A61K9/00, A61P25/18, A61P25/22, A61P25/24
[2020/19]
CPC:
A23L33/135 (EP,KR,US); A61K35/747 (EP,KR,US); A61K9/0073 (KR,US);
A61K9/127 (US); A61P25/18 (EP,US); A61P25/22 (EP,US);
A61P25/24 (EP,US); A23V2002/00 (KR); A23V2200/322 (KR) (-)
Former IPC [2019/26]A61K35/747, A23L33/135, A61K9/00
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/26]  
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ZUSAMMENSETZUNG ZUR PRÄVENTION ODER BEHANDLUNG VON GEISTIGEN STÖRUNGEN MIT LACTOBACILLUS[2019/26]
English:COMPOSITION FOR PREVENTING OR TREATING MENTAL DISORDER, CONTAININGLACTOBACILLUS[2019/26]
French:COMPOSITION PERMETTANT DE PRÉVENIR OU DE TRAITER UN TROUBLE MENTAL, CONTENANT UNE VÉSICULE DÉRIVÉE DE BACTÉRIES D'UNE ESPÈCELACTOBACILLUS[2019/26]
Entry into regional phase04.03.2019Translation filed 
04.03.2019National basic fee paid 
04.03.2019Search fee paid 
04.03.2019Designation fee(s) paid 
04.03.2019Examination fee paid 
Examination procedure04.03.2019Examination requested  [2019/26]
02.11.2020Amendment by applicant (claims and/or description)
04.07.2023Despatch of a communication from the examining division (Time limit: M02)
23.08.2023Reply to a communication from the examining division
12.10.2023Communication of intention to grant the patent
26.01.2024Fee for grant paid
26.01.2024Fee for publishing/printing paid
26.01.2024Receipt of the translation of the claim(s)
Fees paidRenewal fee
28.08.2019Renewal fee patent year 03
26.08.2020Renewal fee patent year 04
20.08.2021Renewal fee patent year 05
18.08.2022Renewal fee patent year 06
29.08.2023Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipNO06.06.2024
[2024/33]
Documents cited:Search[XYI]EP0966969  (CALPIS CO LTD [JP], et al) [X] 1,2,4,6,8,9,11 * paragraph [0018]; claims 1-2 * [Y] 1-11 [I] 1-11;
 [XYI]WO2004098622  (ALIMENTARY HEALTH LTD [IE], et al) [X] 1,2,4,6,8,9,11 * claims 1, 6, 12 * [Y] 1-11 [I] 1-11;
 [XYI]WO2005077391  (SYNBIOTICS AB [SE], et al) [X] 1-3,8-10 * examples 1, 2, 15, 17, 20; claims 1-18 * [Y] 1-11 [I] 1-11;
 [XYI]JP2008081434  (UNIV MIYAZAKI, et al) [X] 1,2,4,6,8,9,11 * claims 1, 2 * [Y] 1-11 [I] 1-11;
 [XYI]WO2008155998  (NAGASE & CO LTD [JP], et al) [X] 1,2,4,6,8,9,11 * claims 1, 5 * [Y] 1-11 [I] 1-11;
 [XYI]KR20090041889  (DUDUWON CO LTD [KR]) [X] 1-3,6,8,9,11 * paragraph [0003] - paragraph [0004]; claim 1 * [Y] 1-11 [I] 1-11;
 [XYI]WO2010060722  (NESTEC SA [CH], et al) [X] 1,2,4,6,8,9,11 * page 8, line 2 - line 25; claims 1, 5, 12 * [Y] 1-11 [I] 1-11;
 [XYI]KR20110025603  (AEON MEDIX INC [KR]) [X] 1,2,6,8-10 * paragraph [0014] - paragraph [0015]; claims 82, 95, 103, 104, 109, 110, 120 * [Y] 1-11 [I] 1-11;
 [XYI]EP2332539  (SUNTORY HOLDINGS LTD [JP]) [X] 1-3,6,8,9,11 * claims 1, 7, 8 * [Y] 1-11 [I] 1-11;
 [XYI]JP2011116666  (API CO LTD) [X] 1-3,6,8,9,11 * claims 1, 3 * [Y] 1-11 [I] 1-11;
 [Y]KR20110082481  (POSTECH ACAD IND FOUND [KR]) [Y] 1-11* claims 1, 15 *;
 [XYI]WO2012089784  (NESTEC SA [CH], et al) [X] 1-4,6,8,9,11 * page 3, line 12 - page 16, line 37 * [Y] 1-11 [I] 1-11;
 [XYI]EP2937424  (UNIV NAT YANG MING [TW]) [X] 1-3,6-9 * paragraph [0050]; claims 1, 4 * [Y] 1-11 [I] 1-11;
 [XYI]WO2016065419  (MEDLAB IP PTY LTD [AU]) [X] 1-4,6,8-11 * claims 1, 8, 14 * [Y] 1-11 [I] 1-11;
 [XYI]WO2016124642  (WINCLOVE HOLDING B V [NL]) [X] 1-3,6,8,9,11 * claims 19, 21 * [Y] 1-11 [I] 1-11;
 [XYI]  - LIU YEN-WENN ET AL, "Psychotropic effects ofLactobacillus plantarumPS128 in early life-stressed and naïve adult mice", BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, (20151124), vol. 1631, doi:10.1016/J.BRAINRES.2015.11.018, ISSN 0006-8993, pages 1 - 12, XP029396287 [X] 1-3,6-9 * the whole document * [Y] 1-11 [I] 1-11

DOI:   http://dx.doi.org/10.1016/j.brainres.2015.11.018
 [XYI]  - EUTAMENE H ET AL, "Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats", THE JOURNAL OF NUTRITION, AMERICAN SOCIETY FOR NUTRITION, US, (20070101), vol. 137, no. 8, ISSN 0022-3166, pages 1901 - 1907, XP008096506 [X] 1,2,6,8,9 * the whole document * [Y] 1-11 [I] 1-11
 [XYI]  - LUTGENDORFF FEMKE ET AL, "The role of microbiota and probiotics in stress-induced gastrointestinal damage", CURRENT MOLECULAR MEDICINE, BENTHAM SCIENCE PUBLISHERS, NL, (20080601), vol. 8, no. 4, ISSN 1566-5240, pages 282 - 298, XP009150148 [X] 1,2,6,8,9,11 * the whole document * [Y] 1-11 [I] 1-11
International search[XY]KR20110025603  (AEON MEDIX INC [KR]) [X] 1-6, 8, 17-22, 24, 26 * See paragraphs [0014], [0015], [0080], [0121] and [0128]; claims 82, 95, 103, 104, 109, 110, 120. * [Y] 7, 9-16, 23;
 [Y]KR20110082481  (POSTECH ACAD IND FOUND [KR]) [Y] 7, 9-16, 23 * See claims 1, 8 and 15. *;
 [A]US2007104738  (TATISCHEFF IRENE [FR], et al) [A] 1-24, 26 * See claim 18. *;
 [A]  - SCHERTZER, J. W. et al., "Bacterial Outer Membrane Vesicles in Trafficking, Communication and the Host-pathogen Interaction", Journal of Molecular Microbiology and Biotechnology, (20130000), vol. 23, doi:doi:10.1159/000346770, pages 118 - 130, XP009185196 [A] 1-24, 26 * See abstract; "Virulence/Predation" section. *

DOI:   http://dx.doi.org/10.1159/000346770
 [A]  - BROWN, L. et al., "Extracellular Vesicles Produced by the Gram-positive Bacterium Bacillus Subtilis Are Disrupted by the Lipopeptide Surfactin", Molecular Microbiology, (20140000), vol. 93, no. 1, doi:doi:10.1111/mmi.12650, pages 183 - 198, XP055466011 [A] 1-24, 26 * See abstract. *

DOI:   http://dx.doi.org/10.1111/mmi.12650
 [A]  - ZABOROWSKI, M. P. et al., "Extracellular Vesicles: Composition, Biological Relevance, and Methods of Study", BioScience, (20150000), vol. 65, no. 8, doi:doi:10.1093/biosci/biv084, pages 783 - 797, XP055466019 [A] 1-24, 26 * See abstract; figure 2. *

DOI:   http://dx.doi.org/10.1093/biosci/biv084
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.